These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11555327)

  • 1. Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats.
    Kii Y; Nakatsuji K; Nose I; Yabuuchi M; Mizuki Y; Ito T
    Pharmacol Toxicol; 2001 Aug; 89(2):96-103. PubMed ID: 11555327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles.
    Kii Y; Ito T
    J Cardiovasc Pharmacol; 1997 May; 29(5):670-5. PubMed ID: 9213211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs.
    Inui A; Yoshikawa T; Nagai R; Yoshida N; Ito T
    Jpn J Pharmacol; 2002 Dec; 90(4):313-20. PubMed ID: 12501007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?
    Carlsson L; Amos GJ; Andersson B; Drews L; Duker G; Wadstedt G
    J Pharmacol Exp Ther; 1997 Jul; 282(1):220-7. PubMed ID: 9223557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.
    Beattie DT; Armstrong SR; Shaw JP; Marquess D; Sandlund C; Smith JA; Taylor JA; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):139-47. PubMed ID: 18408918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized rat.
    Armstrong SR; McCullough JL; Beattie DT
    J Pharmacol Toxicol Methods; 2006; 53(3):198-205. PubMed ID: 16168678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles.
    Hamlin RL; Kijtawornrat A; Keene BW; Hamlin DM
    Toxicol Sci; 2003 Dec; 76(2):437-42. PubMed ID: 14600288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thorough QT/QTc Study Shows That a Novel 5-HT
    Hamatani T; Noda N; Takagaki T; Yodo Y; Kawai H; Kakuyama H; Kaji Y; Fujio Y
    Clin Pharmacol Drug Dev; 2020 Nov; 9(8):938-951. PubMed ID: 32087003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological effects of the gastroprokinetic agent mosapride citrate].
    Yoshida N
    Nihon Yakurigaku Zasshi; 1999 May; 113(5):299-307. PubMed ID: 10480157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interaction between mosapride and erythromycin without electrocardiographic changes.
    Katoh T; Saitoh H; Ohno N; Tateno M; Nakamura T; Dendo I; Kobayashi S; Nagasawa K
    Jpn Heart J; 2003 Mar; 44(2):225-34. PubMed ID: 12718484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities.
    Toga T; Kohmura Y; Kawatsu R
    J Pharmacol Sci; 2007 Oct; 105(2):207-10. PubMed ID: 17928736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical analysis of QT interval as a function of changes in RR interval in the conscious dog.
    Raunig D; Depasquale MJ; Huang CH; Winslow R; Fossa AA
    J Pharmacol Toxicol Methods; 2001; 46(1):1-11. PubMed ID: 12164254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent effects on cisapride-induced QTc prolongation in the isolated guinea pig heart.
    Mittelstadt SW; Adams NA; Spruell RD
    J Pharmacol Toxicol Methods; 2006; 54(2):159-63. PubMed ID: 16624595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced ventricular tachyarrhythmia in isolated rabbit hearts with atrioventricular block.
    Kii Y; Ito T
    Pharmacol Toxicol; 2002 May; 90(5):246-53. PubMed ID: 12076305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of drug-induced QT interval prolongation in conscious rabbits.
    Kijtawornrat A; Ozkanlar Y; Keene BW; Roche BM; Hamlin DM; Hamlin RL
    J Pharmacol Toxicol Methods; 2006; 53(2):168-73. PubMed ID: 16290300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
    Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
    J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mosapride citrate hydrate on the colon cleansing action of polyethylene glycol electrolyte lavage solution (PEG-ELS) in guinea pigs.
    Mine Y; Morikage K; Oku S; Yoshikawa T; Shimizu I; Yoshida N
    J Pharmacol Sci; 2009 Aug; 110(4):415-23. PubMed ID: 19602846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.